Guardant Health (GH) Short-term Investments (2017 - 2026)

Guardant Health has disclosed Short-term Investments across 10 years of filings, most recently posting $113.5 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $113.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $113.5 million (changed N/A YoY), and the FY2025 annual result was $823.4 million, up 161.86% from the prior year.
• Short-term Investments came in at $113.5 million for Q1 2026 at Guardant Health, down from $823.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $953.8 million in Q2 2023 to a low of $35.1 million in Q4 2023.
• The 5-year median for Short-term Investments is $668.0 million (2022), against an average of $554.9 million.
• Across the five-year window, Short-term Investments plunged 95.96% in 2023 and soared 795.91% in 2024, its largest moves.
• Guardant Health's Short-term Investments stood at $869.6 million in 2022, then slumped by 95.96% to $35.1 million in 2023, then jumped by 795.91% to $314.4 million in 2024, then soared by 161.86% to $823.4 million in 2025, then sank by 86.22% to $113.5 million in 2026.
• The last three Short-term Investments figures came in at $113.5 million (Q1 2026), $823.4 million (Q4 2025), and $314.4 million (Q4 2024), per Business Quant data.